Evidence map›Paper›PMID 31061031›Full record

ArticleBMJ open2019

In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.

Padmaa Venkatason, Yong Z Zubairi, Wan Azman Wan Ahmad, Muhammad Imran Hafidz, Muhammad Dzafir Ismail, Mohd Firdaus Hadi, Ahmad Syadi Mahmood Zuhdi

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Padmaa VenkatasonDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Yong Z ZubairiFoundation Studies in Science, University of Malaya, Kuala Lumpur, Malaysia.
Wan Azman Wan AhmadDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Muhammad Imran HafidzDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Muhammad Dzafir IsmailDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.ORCID 0000-0002-7451-1802
Mohd Firdaus HadiDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Ahmad Syadi Mahmood ZuhdiDepartment of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
University Malaya Medical Centre · MYUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCardiogenic shock (CS) complicating ST-elevation myocardial infarction (STEMI) carries an extremely high mortality. The clinical pattern of this life threatening complication has never been described in Malaysian setting. This study is to investigate the incidence, clinical characteristics and outcome of STEMI patients with CS in our population.

designA retrospective analysis of STEMI patients from 18 hospitals across Malaysia contributing to the Malaysian National Cardiovascular Database-acute coronary syndrome) registry (NCVD-ACS) year 2006-2013.

participants16 517 patients diagnosed of STEMI from 18 hospitals in Malaysia from the year 2006 to 2013. PRIMARY OUTCOME MEASURES: In-hospital and 30 day post-discharge mortality.

resultsCS complicates 10.6% of all STEMIs in this study. They had unfavourable premorbid conditions and poor outcomes. The in-hospital mortality rate was 34.1% which translates into a 7.14 times mortality risk increment compared with STEMI without CS. Intravenous thrombolysis remained as the main urgent reperfusion modality. Percutaneous coronary interventions (PCI) in CS conferred a 40% risk reduction over non-invasive therapy but were only done in 33.6% of cases. Age over 65, diabetes mellitus, hypertension, chronic lung and kidney disease conferred higher risk of mortality.

conclusionMortality rates of CS complicating STEMI in Malaysia are high. In-hospital PCI confers a 40% mortality risk reduction but the rate of PCI among our patients with CS complicating STEMI is still low. Efforts are being made to increase access to invasive therapy for these patients.

Indexed as

Hospital MortalityPercutaneous Coronary InterventionAgedAngiotensin-Converting Enzyme InhibitorsAspirinDatabases, FactualFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLogistic ModelsMalaysiaMaleMiddle AgedRegistriesRetrospective StudiesRisk FactorsAngiotensin-Converting Enzyme InhibitorsAspirinHydroxymethylglutaryl-CoA Reductase Inhibitorsacute coronary syndromecardiogenic shockmortalitymyocardial infarctionpercutaneous coronary intervention

Identifiers

PMID31061031
PMCPMC6502239
OpenAlexW2944494384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.